Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Comparison of Safety and Efficacy of Berodual® Administered Via the Respimat® Device With That Administered Via the Metered Dose Inhaler (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial comparing safety and efficacy of Berodual delivered by the Respimat device versus a metered-dose inhaler in patients with chro…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Berodual® Respimat® Versus Berodual® Metered Aerosol (MA) Inhaler in Patients With Asthma, Chronic Obstructive Pulmonary Disease, or Mixed Condition [Phase 3]
Phase 3 trial comparing Berodual Respimat with the Berodual MA Inhaler in patients with asthma, chronic obstructive pulmonary disease, or mi…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Respimat® Inhaler vs a Metered Dose Inhaler Using Berodual® in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 clinical trial comparing the Respimat inhaler with a metered-dose inhaler using Berodual in patients with chronic obstructive pulm…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Berodual® Respimat® vs Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary Disease [Phase 3]
A Phase 3 trial comparing Berodual Respimat with a Metered Dose Inhaler in chronic obstructive pulmonary disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: Ba253BINEB Compared to Ba253MDI (Metered Dose Inhaler) in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 trial comparing Ba253BINEB with Ba253MDI in chronic obstructive pulmonary disease has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: Ba253BINEB in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 clinical trial of Ba253BINEB in chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: An Observational Study to Assess RSV-associated Illness in Adults With COPD and/or CHF
An observational study evaluating RSV-associated illness in adults with COPD and/or congestive heart failure has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Effect of Treatment BI 1744 CL (5 and 10 mcg) Versus Placebo on Exercise Endurance Time During Constant Work Rate Cycle Ergometry I [Phase 3]
Phase 3 trial evaluating BI 1744 CL (5 and 10 mcg) versus placebo on exercise endurance time in COPD patients; the study was completed and r…
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Effect of Treatment BI 1744 CL (5 and 10 mcg) Versus Placebo on Exercise Endurance Time During Constant Work Rate Cycle Ergometry II [Phase 3]
A Phase 3 trial comparing BI 1744 CL (5 and 10 mcg) to placebo assessed exercise endurance time in chronic obstructive pulmonary disease; th…
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Triage of Reduced Exercise Tolerance in Frail Elderly [NA]
A completed clinical trial funded by UMC Utrecht investigating triage for reduced exercise tolerance in frail elderly patients with heart fa…
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Ipratropium or Salbutamol Sulphate Alone or Combination Therapy Salbutamol and Ipratropium in Patients With COPD [Phase 4]
A Phase 4 COPD trial evaluating ipratropium bromide, salbutamol sulfate, or their combination has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Pulmonary Embolism in Exacerbations of Chronic Obstructive Pulmonary Disease
This is a completed clinical trial examining pulmonary embolism in people with chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: Implementation of Telemonitoring in Chronic Heart or Lung Failure [Phase 1]
Phase 1 clinical trial assessing telemonitoring for patients with chronic heart or lung failure has completed. Sponsored by Royal Brompton &…
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: BI 1744 CL With Respimat Once Daily Versus Twice Daily in COPD [Phase 2]
Phase 2 trial comparing once-daily versus twice-daily BI 1744 CL with the Respimat inhaler in chronic obstructive pulmonary disease; trial c…
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease [Phase 3]
Phase 3 study characterizing 24-hour spirometry profiles of inhaled BI 1744 CL versus inhaled formoterol (Foradil) in patients with chronic …
-
CLINICAL_TRIALS trial_result · 2014-06-30Clinical Trial Update: Single Dose Ranging Study of BI 1744 CL (Olodaterol) in Chronic Obstructive Pulmonary Disease [Phase 2]
Phase 2 single-dose dose-ranging study of olodaterol (BI 1744 CL) in chronic obstructive pulmonary disease; the trial completed and results …
-
CLINICAL_TRIALS trial_result · 2014-06-30Clinical Trial Update: Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease [Phase 3]
Phase 3 trial comparing inhaled BI 1744 CL with inhaled tiotropium bromide in chronic obstructive pulmonary disease was completed, with resu…
-
CLINICAL_TRIALS trial_result · 2014-06-30Clinical Trial Update: A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease [Phase 3]
A Phase 3 randomized, double-blind, four-way crossover trial comparing inhaled BI 1744 CL with inhaled tiotropium bromide in chronic obstruc…
-
CLINICAL_TRIALS trial_result · 2014-06-27Clinical Trial Update: Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary Disease [Phase 3]
A Phase 3 study evaluated ipratropium bromide/salbutamol delivered by the Respimat inhaler against ipratropium bromide Respimat, Combivent i…
-
CLINICAL_TRIALS trial_result · 2014-06-27Clinical Trial Update: Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease [Phase 3]
Phase 3 trial characterising 24-hour FEV1 time profiles for inhaled BI 1744 CL and inhaled Foradil in patients with chronic obstructive pulm…
-
CLINICAL_TRIALS trial_result · 2014-06-27Clinical Trial Update: Tiotropium in the Treatment of the Patients With Chronic Obstructive Pulmonary Disease
A completed clinical trial update evaluating tiotropium in the treatment of patients with Chronic Obstructive Pulmonary Disease.
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: Efficacy and Safety of Tiotropium Compared to Salmeterol and Placebo in Patients With Chronic Obstructive Bronchitis (COPD) [Phase 3]
This Phase 3 trial update reports on the efficacy and safety of tiotropium compared with salmeterol and placebo in patients with chronic obs…
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Efficacy and Safety of Ba679BR Powder Inhalation in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
The document reports the completion of a Phase 3 clinical trial evaluating the efficacy and safety of Ba679BR powder inhalation in patients …
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: 12-week Treatment With Inhaled Tiotropium (18 mcg Once Daily) on Lung Function and Static Lung Volumes in Stable, Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients. Correlation to Dyspnoea Scales [Phase 3]
A Phase 3 clinical trial evaluating 12 weeks of once-daily inhaled tiotropium 18 mcg in stable moderate-to-severe COPD assessed effects on l…
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: A 24-week Study to Evaluate the Efficacy and Safety of GSK573719/GW642444 125/25 mcg and 62.5/25mcg Inhalation Powder Compared With Placebo in Subjects With COPD [Phase 3]
A Phase 3 trial comparing two dosages of inhaled GSK573719/GW642444 versus placebo in COPD completed with results posted in 2014.